Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 16, 848-855, October 1, 1956]
© 1956 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pikovski, M. A.
Right arrow Articles by Schlesinger, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pikovski, M. A.
Right arrow Articles by Schlesinger, M.

Conditions Influencing the Degree of Tolerance of Mouse Tumors in Rats Pretreated with Mouse Tissue

Mary A. Pikovski and Michael Schlesinger

( Department of Experimental Pathology, Cancer Research Laboratories, The Hebrew University, Hadassah Medical School, Jerusalem, Israel)

Grafts of the mouse mammary carcinoma of the RIII strain (M.M.C.) can result in tumors in 100 per cent and kill 50–100 per cent of rats pretreated at a suitable age with suitable doses of lyophilized mouse tumors or some normal mouse tissues of mice of the RIII strain.

The pretreatment of older animals, or of young animals with lower doses, results in a weaker effect, characterized by a lower percentage of takes and smaller, regressing tumors. There is a limit to the age and to the dose beyond which the pretreatment produces no effect.

The M.M.C. will grow in adult rats, provided the treatment was started early enough.

The M.M.C. and Sarcoma 37 will grow equally well in rats pretreated with lyophilized preparations of either of these tumors.

Pretreatment with tumor or normal tissue of species other than the mouse produces no effect.

The M.M.C. can grow progressively in rats pretreated with tissues of mice belonging to strains in which the M.M.C. does not grow.

Rats of two sublines of an inbred strain differed conspicuously in their response to treatment.

Received 4/10/56.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1956 by the American Association for Cancer Research.